From week 10 on:
Non-invasive prenatal screening test (Panorama test)
Ultrasound to detect serious morphological abnormalities and to measure the nucal translucency.
Preeclampsia screening for early preeclampsia prevention and providing preventive treatment (salicylic acid).
Prenatal screening for Down Syndrome, Trisomy 13 and 18, Patau Syndrome, and Edwards Syndrome.
Follow-up ultrasound to determine the baby’s gender.
3-D-4-D follow-up ultrasound. The 4-D ultrasound provides more information about babies’ physical malformations.
We request the second trimester blood test in which O’Sullivan’s test is performed (gestational diabetes test).
Follow up ultrasound. At week 28 it is recommended that RhD-negative women receive anti-D immunoglobulin vaccination (Rh vaccination).
At weeks 32 and 34 we perform an ultrasound where we examine the baby’s growth.
We request the final blood test of the pregnancy and perform streptococcus screening (rectovaginal culture). This test detects the presence of streptococcus and if it is positive we can recommend intrapartum antibiotic treatment to prevent neonatal infections.
Follow-up ultrasound. In addition to examining the baby’s growth we will analyse the amount of amniotic fluid and the condition of the placenta.
Last follow-up office visit before delivery. We check the cervix’s status and furnish a detailed report of the patient’s pregnancy.
We also support our patients with whatever they might need prior to delivery (referrals to other centres, questions about procedures, etc. ).